Adagio Medical Holdings, Inc. (ADGM) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Laguna Hills, DE, アメリカ. 現CEOは Todd Usen.
ADGM を有する IPO日 2024-07-23, 80 名の正社員, に上場 NASDAQ Global Market, 時価総額 $21.77M.
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
